SS

Satish Soni

Active Director Director DIN 00399084
DIN 00399084 First appointment Sep 1993 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 1993
Shareholding value •••• Premium profile

About Satish Soni

Data last updated:

Satish Soni is a Director at Precise Pharmaceuticals Private Limited (since 1993). The company operates in Pharma. Precise Pharmaceuticals Private Limited reported revenue of ₹1.85 Cr (FY 2024).

DIN 00399084
Primary Designation Director
Industry Pharma
First Appointment 27 Sep 1993
Oldest Company Age 33 yrs
Largest company Precise Pharmaceuticals Private Limited · ₹1.85 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director27 Sep 19931993₹1.85 Cr (FY 2024)Active

Board colleagues of Satish Soni

NameDINCompanyDesignation
Aditya Soni08595464Precise Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Precise Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Satish Soni

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Satish Soni

Satish Soni currently holds 1 directorship: Precise Pharmaceuticals Private Limited (Director, since 27 Sep 1993, revenue ₹1.85 Cr (FY 2024)).

Satish Soni was first appointed on 27 Sep 1993 as Director at Precise Pharmaceuticals Private Limited.

The current boards of Satish Soni's companies include Aditya Soni (Precise Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available